GNMT and metabolic dysfunction-associated steatotic liver disease: This miRNA has already been reported by our group to act as an epigenetic modulator of GNMT, finding it overexpressed in NAFLD [17] and fibrosis [18] and being inversely correlated with the expression of the enzyme.